US Pharma Company Artelo Announces Launch of Solana Reserve Asset Strategy
BlockBeats News, August 4th, Pharmaceutical company Artelo Biosciences (Nasdaq: ARTL) announced the completion of a $9.475 million off-market private placement, which will be used to launch a Solana (SOL)-centered digital asset reserve strategy, making it the first publicly traded pharmaceutical company to include SOL as a reserve asset.
This private placement includes the issuance of common stock (or pre-funded warrants) at a price of $10.45 per share, as well as two tranches of warrants with exercise prices of $10.20 and $50, respectively, with a three-year term. The transaction is expected to be completed on August 5, 2025.
You may also like
Gainers
Latest Crypto News
Telegram Founder: Decentralized Secure Computation Network Cocoon is Now Live
A Whale Doubles Down on Short Position of Over 6300 ETH, Realizing a Floating Profit of $1 Million in Just 1 Hour
Kalshi Faces Class Action Lawsuit, Accused of Conducting Sports Betting Operations Without a License
Prediction: The first spot LINK ETF will be launched this week
Analysis: The "1011" clearing event and the increasingly challenging macro environment have been the main drivers of the recent downturn.
Customer Support:@weikecs
Business Cooperation:@weikecs
Quant Trading & MM:[email protected]
VIP Services:[email protected]